Patent · US Active

Immunogens comprising human immunodeficiency virus V1/V2 polypeptides

US9988424B2 · kind B2 · utility

0Cited by
9References
20Claims
0Family size

Assignees

Inventors

Key dates

Filing dateDec 5, 2012
Grant dateJun 5, 2018
Priority date—
Expiry dateJul 15, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2740/16134
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention is generally directed to V1V2 immunogens.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.